TW200501938A - A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder - Google Patents

A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder

Info

Publication number
TW200501938A
TW200501938A TW093118021A TW93118021A TW200501938A TW 200501938 A TW200501938 A TW 200501938A TW 093118021 A TW093118021 A TW 093118021A TW 93118021 A TW93118021 A TW 93118021A TW 200501938 A TW200501938 A TW 200501938A
Authority
TW
Taiwan
Prior art keywords
optionally substituted
group
substituted lower
lower alkyl
accompany
Prior art date
Application number
TW093118021A
Other languages
English (en)
Chinese (zh)
Inventor
Kaoru Atsuki
Shiro Shirakura
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of TW200501938A publication Critical patent/TW200501938A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW093118021A 2003-06-27 2004-06-23 A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder TW200501938A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003185476 2003-06-27

Publications (1)

Publication Number Publication Date
TW200501938A true TW200501938A (en) 2005-01-16

Family

ID=33549665

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093118021A TW200501938A (en) 2003-06-27 2004-06-23 A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder

Country Status (4)

Country Link
JP (1) JPWO2005000293A1 (ja)
AR (1) AR044870A1 (ja)
TW (1) TW200501938A (ja)
WO (1) WO2005000293A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014672A1 (fr) * 1995-10-16 1997-04-24 Kyowa Hakko Kogyo Co. Ltd. Composes tricycliques
CN1260220C (zh) * 1997-04-15 2006-06-21 协和发酵工业株式会社 三环类化合物
US20040106671A1 (en) * 2001-03-30 2004-06-03 Tsuyoshi Yamagata Remedies for vesical hyperesthesia
HUP0303610A3 (en) * 2001-03-30 2005-02-28 Kyowa Hakko Kogyo Kk Remedies for vesical stimulation in association with prostatauxe
JP2004529133A (ja) * 2001-03-30 2004-09-24 協和醗酵工業株式会社 前立腺肥大症に伴う膀胱刺激症状治療剤
BR0208420A (pt) * 2001-03-30 2004-03-30 Kyowa Hakko Kogyo Kk Agente terapêutico para bexiga hiperativa, uso do composto tricìclico ou do sal farmaceuticamente aceitável do mesmo, e, método para o tratamento de bexiga hiperativa

Also Published As

Publication number Publication date
WO2005000293A1 (ja) 2005-01-06
JPWO2005000293A1 (ja) 2006-08-03
AR044870A1 (es) 2005-10-05

Similar Documents

Publication Publication Date Title
TW200611907A (en) Fused heterocyclic compound
TW200510440A (en) Novel compounds
NZ598393A (en) Modulators of atp-binding cassette transporters
UA83243C2 (ru) Соединения, которые ингибируют натриезависимый переносчик глюкозы
MX2010008818A (es) Derivado de bicicloamina.
WO2007060257A3 (en) Diketopyrrolo-pyrrole compounds
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
TW200727893A (en) Methods for treating sexual dysfunction
GEP20125589B (en) TRIAZINE COMPOUNDS AS P13 KINASE AND mTOR INHIBITORS
NO20084302L (no) 2-(syklisk amino)-pyrimidonderivater som TPK1-inhibitorer
HK1099284A1 (en) Fused quinoline derivative and use thereof
TW200639158A (en) New compounds with therapeutic effect
DE60236719D1 (de) Purinderivate als antagonisten an purinergen rezeptoren
TW200637539A (en) CTGF inhibitors
TW200732338A (en) Aromatic compound
AU2006325931A8 (en) Amine compound and use thereof for medical purposes
TW200609218A (en) Bicyclic compounds
MX2009012125A (es) Compuestos terapeuticos.
MY163164A (en) Ethynyl derivatives as positive allosteric modulators of the mglur5
MY148684A (en) Dual nk1/nk3 antagonist against schizophrenia
CO6321269A2 (es) Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos beta 2 para el tratamiento de transtornos respiratorios
MX2010001566A (es) Derivado de aminopirazolamida.
MX2011007272A (es) Piperidinas de aroilamino y heteroaroilamino sustituidas como inhibidores de glyt-1.
JO2837B1 (en) Quinoline derivatives acting as antibacterial agents
WO2008110690A3 (fr) Nouveaux derives indoliques, leurs procedes de preparation et leurs utilisations notamment en tant qu'antibacteriens